Company Profile

Cytologix Corporation
Profile last edited on: 2/9/2012      CAGE:       UEI:

Business Identifier: Automation of slide-based cellular diagnostics.Tissue staining instrument
Year Founded
1996
First Award
1999
Latest Award
2002
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

99 Erie Street
Cambridge, MA 02139
   (617) 576-0900
   N/A
   www.dakocytomation.com
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

In Sept 2002, Cytologix was acquired by the Danish firm DakoCytomation. Though maintain facilities in the US, the fim's HQ is now in Denmark. CytoLogix has developed tissue staining instrument used in pathology labs for cancer diagnosis. According to terms of the agreement, DakoCytomation assumed all rights to the product as well as responsibility for continued technical support and customer service. DakoCytomation US has retained the CytoLogix facility in Cambridge for ongoing product development and for customer training and support on the East Coast. CytoLogix develops and commercializes systems for the automation of slide-based cellular diagnostics. The company's first product automates the application of histochemical and immunohistochemical stains to tissue specimens destined for microscopic analysis. The instrument employs a patented technology that creates a reaction chamber on a microscope slide and will allow for eventual use molecular (ISH) stains. The firm is an innovator in laboratory technology for histology, molecular diagnostics and genomics. Its Artisan(R) instrument and reagent system automates complex staining processes for pathology laboratories. The Artisan instrument is the first slide-staining instrument to use individual slide heating, a technology that facilitates superior staining quality.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2002 1 NIH $426,911
Project Title: A High Yield Affinity Cell Separation Technology
2001 2 NIH $1,000,559
Project Title: Synthetic Controls For Immunohistochemical Assays
2000 1 NIH $100,000
Project Title: Instrumentation for In Situ Analysis Tumors

Key People / Management

  Jes Ostergaard -- President

Company News

There are no news available.